Zeria Pharmaceutical Co., Ltd. (TYO:4559)
Japan · Delayed Price · Currency is JPY 2,051.00
-18.00 (-0.87%)
Aug 4, 2026, 10:04 AM JST
Zeria Pharmaceutical Market Cap
Zeria Pharmaceutical has a market cap or net worth of 91.2 billion as of August 3, 2026. Its market cap has decreased by -2.27% in one year.
Market Cap
91.20B
Enterprise Value
102.75B
Revenue
89.16B
Ranking
n/a
PE Ratio
10.79
Stock Price
2,051.00
ChartMarket Cap Chart
Since December 22, 1998, Zeria Pharmaceutical's market cap has increased from 58.12B to 91.20B, an increase of 56.93%. That is a compound annual growth rate of 1.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 91.20B | -1.43% |
| Dec 30, 2025 | 92.52B | -14.05% |
| Dec 30, 2024 | 107.64B | 21.07% |
| Dec 29, 2023 | 88.91B | -11.00% |
| Dec 30, 2022 | 99.90B | 12.78% |
| Dec 30, 2021 | 88.58B | 0.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nippon Shinyaku | 229.16B |
| Towa Pharmaceutical | 197.16B |
| Sawai Group Holdings | 190.61B |
| Kissei Pharmaceutical | 169.33B |
| Kaken Pharmaceutical | 143.71B |
| Mochida Pharmaceutical | 110.51B |
| KYORIN Pharmaceutical | 65.62B |
| ASKA Pharmaceutical Holdings | 61.08B |